Document Type : Original Research Article

Authors

1 Georgian Center for Neuroscience Research, International Center for Intelligent Research, Tbilisi, Georgia.

2 MD, Georgian Center for Neuroscience Research, International Center for Intelligent Research, Tbilisi, Georgia.

Abstract

Background and purpose:Antioxidants are known to have protective and beneficial effects in the depression. Menthol is an antioxidant compounds in some plants. On the basis of our knowledge, no scientific study has investigated the antidepressant-like effects of menthol. Therefore, present study was thus conducted to evaluate the antidepressant-like effects of menthol by forced swimming test (FST) through dopaminergic system in a mice model.
Materials and Methods: The mice were intra-peritoneally (i.p.) administrated with menthol (10-30 mg/kg) 1 h before the FST. For evaluating the involvement of the dopaminergic system in the antidepressant activity of menthol, SCH 23390 (a dopamine D1 receptor antagonist), sulpiride (a dopamine D2 receptor antagonist) and haloperidol (non-selective dopamine receptor antagonist) were administered 15 min before menthol administration (10 mg/kg).
Results:Intra-peritoneally administration of menthol reduced immobility time and increased swimming and climbing times. It did not also cause significant changes in spontaneous locomotor function in the open-field test (OFT). In addition, pre-treatment of the mice with SCH23390, sulpiride, haloperidol blocked the anti-immobility effect of menthol in the FST.
Conclusion: Administration of menthol exerted antidepressant-like effects through dopaminergic (D1 and D2) system.

Graphical Abstract

The Antidepressant-Like Effects of Menthol Via Dopaminergic System Using Forced Swimming Test in a Mice Model

Keywords

1.            Sedighi S, Nasiri B, Alipoor R, Moradi-Kor N. Modulation of 6-Gingerol in antidepressant-like effects: An investigation of serotonergic system in mice model. GMJ Med. 2017; 1(1): 21-25. [crossref]

2.            Lambert G, Johansson M, Agren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatr. 2000; 57(8): 787-793. [crossref]

3.            Serra G, Agriolas A, Klimek V, Fadda F, Gessa GL. Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci. 1979; 25(5): 415–423. [crossref]

4.            Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Progr Neuro-Psychopharmacol Biol Psychiatry. 2011; 35(3): 276-692.  [crossref]

5.            Lucca G, Comim CM, Valvassori SS. Increased oxidative stress in sub mitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatric Res. 2009; 43(9): 864-9. [crossref]

6.            Scapagnini G, Davinelli S, Drago F, de Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction. CNS Drug. 2012; 26(6): 477-90. [crossref]

7.            Mesbahzadeh B, Garmsiri M, Jalalvand F, Shojaie L, Kakar MA. Oral administration of menthol could alleviate adverse effects of polycystic ovarian syndrome in blood biochemical parameters and antioxidant status in experimental Wister rats. GMJ Med. 2017; 1(1): 9-14. [crossref]

8.            Abbasi-Maleki S, Bakhtiarian A, Nikoui V. Involvement of the monoaminergic system in the antidepressant-like effect of the crude extract of Mentha piperita (Lamiaceae) in the forced swimming test in mice. Synergy. 2017; 5: 21-28. [crossref]

9.            Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1983; 54(4): 275‑87. [crossref]

10.          Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test antidepressants. Arch Int Pharmacodyn Ther. 1977; 229(2): 327-336. [PMID]

11.          Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson JC. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol. 2002; 12(5): 461–475. [PMID]

12.          Blier P. Possible neurobiological mechanisms underlying faster onset of antidepressant action. J Clin Psychiatry. 2001; 62(4): 7–11. [PMID]

13.          Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry. 1992; 10: 3–7. [PMID]

14.          Xue JS, Li H, Deng X, Fu Q, Ma S. L-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters. Pharmacol Biochem Behav. 2015; 134: 42–48.  [crossref]

15.          Gomes B, Feitosa ML, Silva MIG, Noronha EC, Moura BA, Venancio ET. Anxiolytic-like effect of the monoterpene 1, 4-cineole in mice. Pharmacol Biochem Behav. 2010; 96(3): 287–293. [crossref]

16.          Ozturk Y, Aydm S, Tecik B, Baser K. Effects of essential oils from certain Ziziphora species on swimming performance in mice. Phytother Res. 1995; 9: 225–227. [crossref]

17.          Hirano S, Miyata S, Onodera K, Kamei J. Involvement of dopamine D 1 receptors and a 1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test. Eur J Pharmacol. 2007; 562(1-2): 72-76. [crossref]

18.          Machado DG, Kaster MP, Binfare RW, Dias M, Santos AR, Pizzolatti MG. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(2): 421-428. [crossref]

 

19.          Yamada J, Sugimoto Y, Yamada S. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol. 2004; 504(3): 207–211. [crossref]

20.          Abbasi-Maleki S, Mousavi SZ. Hydroethanolic extract of Carthamus tinctorius induces antidepressant-like effects: modulation by dopaminergic and serotonergic systems in tail suspension test in mice. Iran J Basic Med Sci. 2017; 20(9): 1063–1073. [crossref]

21.          Takamura N, Nakagawa S, Masuda T, Boku S, Kato A, Song N. The effect of dopamine on adult hippocampal neurogenesis. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 50: 116–124. [crossref]